Literature DB >> 496549

Long-term outcome of major psychoses. II. Schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group.

M T Tsuang, G M Dempsey.   

Abstract

Eighty-five patients with both schizophrenic and affective features at the time of admission to the University of Iowa Psychiatric Hospital between 1934 and 1944 were selected for a 30- to 40-year outcome study. Comparison groups were 200 schizophrenic and 325 affective disorder patients, selected by the Feighner et at criteria, and 160 psychiatric symptom-free surgical patients. We assessed marital, residential, occupational, and psychiatric status to evaluate the outcome of these patients at the time of field follow-up. We used multivariate analysis of covariance to analyze the data by taking admission marital and occupational status into consideration. Patients with schizoaffective disorders had a significantly better outcome than those with schizophrenia, but a significantly poorer outcome than those with affective disorders and surgical conditions. Schizoaffective disorder fell somewhere in between the schizophrenia and mania group. Before final conclusions could be made about the nature of schizoaffective disorders, more research should be done.

Entities:  

Mesh:

Year:  1979        PMID: 496549     DOI: 10.1001/archpsyc.1979.01780120032004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  12 in total

1.  Structural Brain Alterations in Youth With Psychosis and Bipolar Spectrum Symptoms.

Authors:  Maria Jalbrzikowski; David Freedman; Catherine E Hegarty; Eva Mennigen; Katherine H Karlsgodt; Loes M Olde Loohuis; Roel A Ophoff; Raquel E Gur; Carrie E Bearden
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-01-18       Impact factor: 8.829

2.  Reliability and validity of the life functioning assessment inventory (L-FAI) for patients with psychosis.

Authors:  Christy Lai-Ming Hui; Yuet-Keung Li; Kwok-Fai Leung; Jennifer Yee-Man Tang; Gloria Hoi-Yan Wong; Wing-Chung Chang; Sherry Kit-Wa Chan; Edwin Ho-Ming Lee; Eric Yu-Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-03-26       Impact factor: 4.328

3.  The clinical characterization of the patient with primary psychosis aimed at personalization of management.

Authors:  Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

4.  The impact of a changing system of care on patterns of utilization by schizophrenics.

Authors:  H Häfner; W an der Heiden
Journal:  Soc Psychiatry       Date:  1983

Review 5.  Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?

Authors:  Lennart B Jansson; Josef Parnas
Journal:  Schizophr Bull       Date:  2006-12-08       Impact factor: 9.306

Review 6.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

Review 7.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

8.  Premorbid abnormalities in mania, schizomania, acute schizophrenia and chronic schizophrenia.

Authors:  J van Os; N Takei; D J Castle; S Wessely; G Der; R M Murray
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-11       Impact factor: 4.328

9.  Schizo-affective psychoses in childhood: a follow-up study.

Authors:  C Eggers
Journal:  J Autism Dev Disord       Date:  1989-06

Review 10.  Costs of bipolar disorder.

Authors:  Leah Kleinman; Ana Lowin; Emuella Flood; Gian Gandhi; Eric Edgell; Dennis Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.